Order Article Reprints

Alshabrawy AK, Cui Y, Sylvester C, Yang D, Petito ES, Barratt KR, Sawyer RK, Heatlie JK, Polara R, Sykes MJ, et al. Therapeutic Potential of a Novel Vitamin D₃ Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules. 2022; 12(7):960. https://doi.org/10.3390/biom12070960

Alshabrawy, Ali K., Yingjie Cui, Cyan Sylvester, Dongqing Yang, Emilio S. Petito, Kate R. Barratt, Rebecca K. Sawyer, Jessica K. Heatlie, Ruhi Polara, Matthew J. Sykes, and et al. 2022. "Therapeutic Potential of a Novel Vitamin D₃ Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding" Biomolecules 12, no. 7: 960. https://doi.org/10.3390/biom12070960

Alshabrawy, A. K., Cui, Y., Sylvester, C., Yang, D., Petito, E. S., Barratt, K. R., Sawyer, R. K., Heatlie, J. K., Polara, R., Sykes, M. J., Atkins, G. J., Hickey, S. M., Wiese, M. D., Stringer, A. M., Liu, Z., & Anderson, P. H. (2022). Therapeutic Potential of a Novel Vitamin D₃ Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules, 12(7), 960. https://doi.org/10.3390/biom12070960